Search

Your search keyword '"Hofma, Sjoerd H."' showing total 223 results
Start Over Author "Hofma, Sjoerd H."
223 results on '"Hofma, Sjoerd H."'

1. Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study

Author

Dillen, Daimy M.M., Vlaar, Pieter Jan, Vermeer, Amy J.E., Paradies, Valeria, van Kuijk, Jan- Peter, Vink, Maarten A., Oemrawsingh, Rohit M., Hofma, Sjoerd H., Magro, Michael, Remkes, Wouter S., de Smet, Bart J.G.L., van Rees, Johannes B., Somi, Samer, Halim, Jonathan, Zimmermann, Frederik M., Wijnbergen, Inge F., Tijssen, Jan G.P., Tonino, Pim A.L., and Teeuwen, Koen

Published
2023
Full Text
View/download PDF

4. Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER III

Author

Garot, Philippe, Leon, Martin B., Saito, Shigeru, Baumbach, Andreas, Kereiakes, Dean J., Windecker, Stephan, Pietras, Cody, Dressler, Ovidiu, Issever, M. Ozgu, Curtis, Michael, Bertolet, Barry D., Zidar, James P., Smits, Pieter C., Jiménez Diaz, Victor Alfonso, McLaurin, Brent, Cequier, Angel R., Hofma, Sjoerd H., Dib, Nabil, Namiki, Atsuo, Takahashi, Akihiko, Kakuta, Tsunekazu, Hirohata, Atsushi, and Lansky, Alexandra J.

Published
2023
Full Text
View/download PDF

5. Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design

Author

Hara, Hironori, Serruys, Patrick W., O'Leary, Neil, Gao, Chao, Murray, Alicia, Breslin, Elaine, Garg, Scot, Bureau, Christophe, Reiber, Johan HC, Barbato, Emanuele, Aminian, Adel, Janssens, Luc, Rosseel, Liesbeth, Benit, Edouard, Campo, Gianluca, Guiducci, Vincenzo, Casella, Gianni, Santarelli, Andrea, Franzè, Alfonso, Diaz, Victor Alfonso Jimenez, Iñiguez, Andrés, Brugaletta, Salvatore, Sabate, Manel, Amat-Santos, Ignacio J., Amoroso, Giovanni, Wykrzykowska, Joanna, von Birgelen, Clemens, Somi, Samer, Liu, Tommy, Hofma, Sjoerd H., Curzen, Nick, Trillo, Ramiro, Ocaranza, Raymundo, Mathur, Anthony, Smits, Pieter C., Escaned, Javier, Baumbach, Andreas, Wijns, William, Sharif, Faisal, and Onuma, Yoshinobu

Published
2022
Full Text
View/download PDF

6. Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction

Author

Chichareon, Ply, Modolo, Rodrigo, Collet, Carlos, Tenekecioglu, Erhan, Vink, Maarten A., Oh, Pyung Chun, Ahn, Jung-Min, Musto, Carmine, Díaz de la Llera, Luis S., Cho, Young-Seok, Violini, Roberto, Park, Seung-Jung, Suryapranata, Harry, Piek, Jan J., de Winter, Robbert J., Wykrzykowska, Joanna J., Spaulding, Christian, Kang, Woong Chol, Slagboom, Ton, Hofma, Sjoerd H., Wijnbergen, Inge F., Di Lorenzo, Emilio, Pijls, Nico H., Räber, Lorenz, Brugaletta, Salvatore, Sabaté, Manel, Stoll, Hans-Peter, Stone, Gregg W., Windecker, Stephan, Onuma, Yoshinobu, and Serruys, Patrick W.

Published
2019
Full Text
View/download PDF

7. A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial

Author

de Winter, Robbert J, Katagiri, Yuki, Asano, Taku, Milewski, Krzysztof P, Lurz, Philipp, Buszman, Pawel, Jessurun, Gillian A J, Koch, Karel T, Troquay, Roland P T, Hamer, Bas J B, Ophuis, Ton Oude, Wöhrle, Jochen, Wyderka, Rafał, Cayla, Guillaume, Hofma, Sjoerd H, Levesque, Sébastien, Żurakowski, Aleksander, Fischer, Dieter, Kośmider, Maciej, Goube, Pascal, Arkenbout, E Karin, Noutsias, Michel, Ferrari, Markus W, Onuma, Yoshinobu, Wijns, William, and Serruys, Patrick W

Published
2018
Full Text
View/download PDF

8. The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial

Author

Tijssen, Ruben Y. G., Kerkmeijer, Laura S. M., Katagiri, Yuki, Kraak, Robin P., Takahashi, Kuniaki, Kogame, Norihiro, Chichareon, Ply, Modolo, Rodrigo, Asano, Taku, Nassif, Martina, Kalkman, Deborah N., Sotomi, Yohei, Collet, Carlos, Hofma, Sjoerd H., van der Schaaf, Rene J., Arkenbout, E. Karin, Weevers, Auke P. J. D., Beijk, Marcel A. M., Piek, Jan J., Tijssen, Jan G. P., Henriques, Jose P., de Winter, Robbert J., Onuma, Yoshinobu, Serruys, Patrick W., and Wykrzykowska, Joanna J.

Published
2019
Full Text
View/download PDF

10. Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy

Author

Yamaji, Kyohei, Brugaletta, Salvatore, Sabaté, Manel, Iñiguez, Andrés, Jensen, Lisette Okkels, Cequier, Angel, Hofma, Sjoerd H., Christiansen, Evald Høj, Suttorp, Maarten, van Es, Gerrit Anne, Sotomi, Yohei, Onuma, Yoshinobu, Serruys, Patrick W., Windecker, Stephan, and Räber, Lorenz

Published
2017
Full Text
View/download PDF

11. Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent)

Author

Vlachojannis, Georgios J., Smits, Pieter C., Hofma, Sjoerd H., Togni, Mario, Vázquez, Nicolás, Valdés, Mariano, Voudris, Vassilis, Slagboom, Ton, Goy, Jean-Jaques, den Heijer, Peter, and van der Ent, Martin

Published
2017
Full Text
View/download PDF

14. The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents: A Substudy of the RESOLUTE All Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention)

Author

Stefanini, Giulio G., Serruys, Patrick W., Silber, Sigmund, Khattab, Ahmed A., van Geuns, Robert J., Richardt, Gert, Buszman, Pawel E., Kelbæk, Henning, van Boven, Adrianus J., Hofma, Sjoerd H., Linke, Axel, Klauss, Volker, Wijns, William, Macaya, Carlos, Garot, Philippe, Di Mario, Carlo, Manoharan, Ganesh, Kornowski, Ran, Ischinger, Thomas, Bartorelli, Antonio L., Gobbens, Pierre, and Windecker, Stephan

Published
2011
Full Text
View/download PDF

15. The Prognostic Utility of the SYNTAX Score on 1-Year Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents: A Substudy of the RESOLUTE All Comers Trial

Author

Garg, Scot, Serruys, Patrick W., Silber, Sigmund, Wykrzykowska, Joanna, van Geuns, Robert Jan, Richardt, Gert, Buszman, Pawel E., Kelbæk, Henning, van Boven, Adrianus Johannes, Hofma, Sjoerd H., Linke, Axel, Klauss, Volker, Wijns, William, Macaya, Carlos, Garot, Philippe, DiMario, Carlo, Manoharan, Ganesh, Kornowski, Ran, Ischinger, Thomas, Bartorelli, Antonio, Van Remortel, Eric, Ronden, Jacintha, and Windecker, Stephan

Published
2011
Full Text
View/download PDF

16. Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: the Dutch Cangrelor registry

Author

Selvarajah, Abi, primary, Tavenier, Annerieke H, additional, Bor, Wilbert L, additional, Houben, Vital, additional, Rasoul, Saman, additional, Kaplan, Eliza, additional, Teeuwen, Koen, additional, Hofma, Sjoerd H, additional, Lipsic, Erik, additional, Amoroso, Giovanni, additional, van Leeuwen, Maarten A H, additional, ten Berg, Jur M, additional, van ‘t Hof, Arnoud W J, additional, and Hermanides, Renicus S, additional

Published
2021
Full Text
View/download PDF

17. Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial

Author

Sabaté, Manel, Windecker, Stephan, Iñiguez, Andres, Okkels-Jensen, Lisette, Cequier, Angel, Brugaletta, Salvatore, Hofma, Sjoerd H., Räber, Lorenz, Christiansen, Evald Høi, Suttorp, Maarten, Pilgrim, Thomas, Anne van Es, Gerrit, Sotomi, Yohei, García-García, Hector M., Onuma, Yoshinobu, and Serruys, Patrick W.

Published
2016
Full Text
View/download PDF

18. The Influence of Implantation Techniques on Lesion-Oriented Outcomes in Absorb BVS and Xience EES Lesions Treated in Routine Clinical Practice at Complete Three-Year Follow-Up - AIDA Trial QCA Substudy

Author

Tijssen, Ruben Y., primary, Kerkmeijer, Laura S., additional, Takahashi, Kuniaki, additional, Kogame, Norihiro, additional, Katagiri, Yuki, additional, Kraak, Robin P., additional, Chichareon, Ply, additional, Modolo, Rodrigo, additional, Asano, Taku, additional, Nassif, Martina, additional, Kalkman, Deborah N., additional, Sotomi, Yohei, additional, Collet, Carlos, additional, Hofma, Sjoerd H., additional, van der Schaaf, Rene J., additional, Arkenbout, E. Karin, additional, Weevers, Auke, additional, Piek, Jan J., additional, Tijssen, Jan G., additional, Henriques, Jose P., additional, de Winter, Robbert J., additional, Onuma, Yoshinobu, additional, Serruys, Patrick W., additional, and Wykrzykowska, Joanna J., additional

Published
2021
Full Text
View/download PDF

19. Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients

Author

Claassens, Daniel M.F., primary, Gimbel, Marieke E., additional, Bergmeijer, Thomas O., additional, Vos, Gerrit J.A., additional, Hermanides, Renicus S., additional, van der Harst, Pim, additional, Barbato, Emanuele, additional, Morisco, Carmine, additional, Tjon Joe Gin, Richard M., additional, de Vrey, Evelyn A., additional, Heestermans, Ton A.C.M., additional, Jukema, J. Wouter, additional, von Birgelen, Clemens, additional, Waalewijn, Reinier A., additional, Hofma, Sjoerd H., additional, den Hartog, Frank R., additional, Voskuil, Michiel, additional, van't Hof, Arnoud W.J., additional, Asselbergs, Folkert W., additional, Mosterd, A., additional, Herrman, Jean-Paul R., additional, Dewilde, Willem, additional, Mahmoodi, Bakhtawar K., additional, Deneer, Vera H.M., additional, and ten Berg, Jurriën M., additional

Published
2021
Full Text
View/download PDF

20. Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial

Author

Tomaniak, Mariusz, Chichareon, Ply, Onuma, Yoshinobu, Deliargyris, Efthymios N., Takahashi, Kuniaki, Kogame, Norihiro, Modolo, Rodrigo, Chang, Chun Ching, Rademaker-Havinga, Tessa, Storey, Robert F., Dangas, George D., Bhatt, Deepak L., Angiolillo, Dominick J., Hamm, Christian, Valgimigli, Marco, Windecker, Stephan, Steg, Philippe Gabriel, Vranckx, Pascal, Serruys, Patrick W., Bertrand, Olivier F., Plante, Sylvain, Van Geuns, Robert-Jan, Hofma, Sjoerd H., Royaards, Kees-Jan, Slagboom, Ton, Suryapranata, Harry, Umans, Victor A. W. M., Rensing, Benno, van der Harst, Pim, Magro, Michael, Barbato, Emanuel, Aminian, Adel, Benit, Edouard, Janssens, Luc, Vrolix, Mathias, Buysschaert, Ian, Carrie, Didier, Barraud, Pascal, Teiger, Emmanuel, Koning, Ren, Farzin, Beygui, Morelle, Jean-francois, Isaaz, Karl, Maillard, Luc, Abdellaoui, Mohamed, Brunel, Philippe, Angioi, Michael, Lantelme, Pierre, Sabate, Manel, Albarran Gonzalez-Trevilla, Agustin, Cardiology, Graduate School, ACS - Atherosclerosis & ischemic syndromes, ACS - Microcirculation, ACS - Heart failure & arrhythmias, and Cardiovascular Centre (CVC)

Subjects
Male, Ticagrelor, Internationality, Time Factors, medicine.medical_treatment, 030204 cardiovascular system & hematology, Severity of Illness Index, Tertiary Care Centers, Coronary artery disease, 0302 clinical medicine, Cause of Death, 030212 general & internal medicine, 610 Medicine & health, Original Investigation, Aspirin, DUAL ANTIPLATELET THERAPY, Continuity of Patient Care, Clopidogrel, Treatment Outcome, CLOPIDOGREL, Platelet aggregation inhibitor, Drug Therapy, Combination, Female, Cardiology and Cardiovascular Medicine, INTERVENTION, medicine.drug, Acute coronary syndrome, medicine.medical_specialty, Hemorrhage, Risk Assessment, Drug Administration Schedule, 03 medical and health sciences, Percutaneous Coronary Intervention, Internal medicine, medicine, Humans, Acute Coronary Syndrome, Dose-Response Relationship, Drug, RECEPTOR, business.industry, Percutaneous coronary intervention, IN-VITRO, medicine.disease, Survival Analysis, PLATO, Conventional PCI, business, Platelet Aggregation Inhibitors, Follow-Up Studies
Abstract

Key PointsQuestionWhat are the benefits and risks of continuing aspirin in addition to P2Y12 receptor inhibition with ticagrelor among patients with acute coronary syndrome between 1 month and 12 months after percutaneous coronary intervention? FindingsIn this nonprespecified, post hoc analysis of the GLOBAL LEADERS randomized clinical trial, beyond 1 month after percutaneous coronary intervention in acute coronary syndrome, aspirin was associated with increased bleeding risk and appeared not to add to the benefit of ticagrelor on ischemic events. MeaningThe findings of this hypothesis-generating analysis pave the way for further trials evaluating aspirin-free antiplatelet strategies after percutaneous coronary intervention.ImportanceThe role of aspirin as part of antiplatelet regimens in acute coronary syndromes (ACS) needs to be clarified in the context of newer potent P2Y12 antagonists. ObjectiveTo evaluate the benefit and risks of aspirin in addition to ticagrelor among patients with ACS beyond 1 month after percutaneous coronary intervention (PCI). Design, Setting, and ParticipantsThis is a nonprespecified, post hoc analysis of GLOBAL LEADERS, a randomized, open-label superiority trial comparing 2 antiplatelet treatment strategies after PCI. The trial included 130 secondary/tertiary care hospitals in different countries, with 15991 unselected patients with stable coronary artery disease or ACS undergoing PCI. Patients had outpatient visits at 1, 3, 6, 12, 18, and 24 months after index procedure. InterventionsThe experimental group received aspirin plus ticagrelor for 1 month followed by 23-month ticagrelor monotherapy; the reference group received aspirin plus either clopidogrel (stable coronary artery disease) or ticagrelor (ACS) for 12 months, followed by 12-month aspirin monotherapy. In this analysis, we examined the clinical outcomes occurring between 31 days and 365 days after randomization, specifically in patients with ACS who, within this time frame, were assigned to receive either ticagrelor alone or ticagrelor and aspirin. Main Outcomes and MeasuresThe primary outcome was the composite of all-cause death or new Q-wave myocardial infarction. ResultsOf 15968 participants, there were 7487 patients with ACS enrolled; 3750 patients were assigned to the experimental group and 3737 patients to the reference group. Between 31 and 365 days after randomization, the primary outcome occurred in 55 patients (1.5%) in the experimental group and in 75 patients (2.0%) in the reference group (hazard ratio [HR], 0.73; 95% CI, 0.51-1.03; P=.07); investigator-reported Bleeding Academic Research Consortium-defined bleeding type 3 or 5 occurred in 28 patients (0.8%) in the experimental group and in 54 patients (1.5%) in the reference arm (HR, 0.52; 95% CI, 0.33-0.81; P=.004). Conclusions and RelevanceBetween 1 month and 12 months after PCI in ACS, aspirin was associated with increased bleeding risk and appeared not to add to the benefit of ticagrelor on ischemic events. These findings should be interpreted as exploratory and hypothesis generating; however, they pave the way for further trials evaluating aspirin-free antiplatelet strategies after PCI. Trial RegistrationClinicalTrials.gov identifier: NCT01813435.This secondary analysis of the GLOBAL LEADERS randomized clinical trial evaluates the benefit and risks of aspirin in addition to ticagrelor among patients with acute coronary syndrome beyond 1 month after percutaneous coronary intervention.

Published
2019

21. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

Author

Serruys, Patrick W., Silber, Sigmund, SerruysGarg, Scot, Jan van Geuns, Robert, Richardt, Gert, Buszman, Pawel E., Kelbaek, Henning, van Boven, Adrainus Johannes, Hofma, Sjoerd H., Linke, Axel, Klauss, Volker, Wijns, William, Macaya, Carlos, Garot, Philippe, DiMario, Carlo, Manoharan, Ganesh, Kornowski, Ran, Ichinger, Thomas, Bartorelli, Antonio, Ronden, Jacintha, Gobbens, Pierre, Bressers, Marco, Negoita, Manuela, van Leeuwen, Frank, and Windecker, Stephan

Subjects
Coronary stenosis -- Health aspects, Coronary stenosis -- Patient outcomes
Abstract

A multicenter, noninferiority randomized trial was conducted for patients undergoing treatment with coronary stents releasing either zotarolimus or everolimus to determine the differences in efficacy and safety between the two types of stents. The new-generation zotarolimus-eluting stent was found to be non-inferior to the everolimus-eluting stent in a population of patients who had minimal exclusion criteria.

Published
2010

22. Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial

Author

Kraak, Robin P., primary, Tijssen, Ruben Yannick G., additional, van Dongen, Ivo M., additional, Elias, Joelle, additional, Hofma, Sjoerd H., additional, van der Schaaf, Rene J., additional, Arkenbout, E. Karin, additional, Weevers, Auke, additional, Tijssen, Jan G.P., additional, Piek, Jan J., additional, de Winter, Robbert J., additional, Henriques, Jose P.S., additional, and Wykrzykowska, Joanna J., additional

Published
2020
Full Text
View/download PDF

23. Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus— AIDA sub‐study

Author

Kerkmeijer, Laura S.M., primary, Tijssen, Ruben Y.G., additional, Hofma, Sjoerd H., additional, Schaaf, Rene J., additional, Arkenbout, E. Karin, additional, Weevers, Auke P.J.D., additional, Kraak, Robin P., additional, Onuma, Yoshinobu, additional, Serruys, Patrick W., additional, Piek, Jan J., additional, Tijssen, Jan G.P., additional, Henriques, Jose P.S., additional, Winter, Robbert J., additional, and Wykrzykowska, Joanna J., additional

Published
2020
Full Text
View/download PDF

24. Final 3-Year Outcomes of MiStent Biodegradable Polymer Crystalline Sirolimus-Eluting Stent Versus Xience Permanent Polymer Everolimus-Eluting Stent

Author

Takahashi, Kuniaki, primary, Serruys, Patrick W., additional, Kogame, Norihiro, additional, Buszman, Paweł, additional, Lurz, Philipp, additional, Jessurun, Gillian A.J., additional, Koch, Karel T., additional, Troquay, Roland P.T., additional, Hamer, B.J.B, additional, Oude Ophuis, Ton, additional, Milewski, Krzysztof P., additional, Hofma, Sjoerd H., additional, Wykrzykowska, Joanna J., additional, Onuma, Yoshinobu, additional, de Winter, Robbert J., additional, and Wijns, William, additional

Published
2020
Full Text
View/download PDF

25. A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial

Author

Kerkmeijer, Laura S.M., primary, Tijssen, Ruben Y.G., additional, Hofma, Sjoerd H., additional, Pinxterhuis, Tineke H., additional, Kraak, Robin P., additional, Kalkman, Deborah N., additional, van der Schaaf, Rene J., additional, Arkenbout, E. Karin, additional, Weevers, Auke P.J.D., additional, Beijk, Marcel A., additional, Baan, Jan, additional, Vis, M. Marije, additional, Koch, Karel T., additional, Tijssen, Jan G.P., additional, Piek, Jan J., additional, Henriques, Jose P.S., additional, de Winter, Robbert J., additional, and Wykrzykowska, Joanna J., additional

Published
2020
Full Text
View/download PDF

26. The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudy

Author

Tijssen, Ruben Y. G., primary, Kerkmeijer, Laura S. M., additional, Takahashi, Kuniaki, additional, Kogame, Norihiro, additional, Katagiri, Yuki, additional, Kraak, Robin P., additional, Chichareon, Ply, additional, Modolo, Rodrigo, additional, Asano, Taku, additional, Nassif, Martina, additional, Kalkman, Deborah N., additional, Sotomi, Yohei, additional, Collet, Carlos, additional, Hofma, Sjoerd H., additional, van der Schaaf, Rene J., additional, Arkenbout, E. Karin, additional, Weevers, Auke P. J. D., additional, Piek, Jan J., additional, Tijssen, Jan G. P., additional, Henriques, Jose P., additional, de Winter, Robbert J., additional, Onuma, Yoshinobu, additional, Serruys, Patrick W., additional, and Wykrzykowska, Joanna J., additional

Published
2020
Full Text
View/download PDF

27. Four-Year Follow-Up of Absorb BVS Compared to Xience EES in Daily Clinical Practice Shows Continued Accrual of Events

Author

Kerkmeijer, Laura, primary, Tijssen, RubenY.G., additional, Hofma, Sjoerd H., additional, van der Schaaf, Rene J., additional, Arkenbout, E. Karin, additional, Weevers, Auke P.J.D., additional, Garcia-Garcia, Hector M., additional, Mcfadden, Eugene, additional, Piek, Jan J., additional, de Winter, Robbert J., additional, Tijssen, JanG.P., additional, Henriques, Jose P.S., additional, and Wykrzykowska, Joanna J., additional

Published
2020
Full Text
View/download PDF

28. TCT-636 Impact of Diabetes on the Outcomes in Patients Undergoing Contemporary Percutaneous Coronary Intervention: Analysis From the GLOBAL LEADERS Study

Author

Chichareon, Ply, primary, Modolo, Rodrigo, additional, Kogame, Norihiro, additional, Takahashi, Kuniaki, additional, Chang, Chun-Chin, additional, Tomaniak, Mariusz, additional, Raffel, Christopher, additional, Botelho, Roberto, additional, Eeckhout, Eric, additional, Hofma, Sjoerd H., additional, Trendafilova, Diana, additional, Koszegi, Zsolt, additional, Iñiguez, Andres, additional, Wykrzykowska, Joanna, additional, Piek, Jan, additional, Garg, Scot, additional, Hamm, Christian, additional, Juni, Peter, additional, Valgimigli, Marco, additional, Windecker, Stephan, additional, Onuma, Yoshinobu, additional, and Serruys, Patrick, additional

Published
2019
Full Text
View/download PDF

29. TCT-41 A Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin-Strut Sirolimus-Eluting Coronary Stent Supraflex: 2-Year Results of the TALENT Trial

Author

Serruys, Patrick, primary, Zaman, Azfar, additional, de Winter, Robert, additional, Kogame, Norihiro, additional, Modolo, Rodrigo, additional, Tonino, Pim, additional, Hofma, Sjoerd H., additional, Smits, Pieter, additional, Prokopczuk, Janusz, additional, Moreno, Raul, additional, Choudhury, Anirban, additional, Petrov, Ivo, additional, Cequier, Angel, additional, Kukreja, Neville, additional, Ungi, Imre, additional, Serra, Antonio, additional, Gil, Robert, additional, Walsh, Simon, additional, Mathur, Anthony, additional, Merkely, Bela, additional, Colombo, Antonio, additional, Ijsselmuiden, Alexander, additional, Soliman, Osama, additional, and Onuma, Yoshinobu, additional

Published
2019
Full Text
View/download PDF

30. TCT-164 Clinical Outcomes at 3 Years of the Absorb Bioresorbable Vascular Scaffold Versus Xience Drug-Eluting Metallic Stent in Patients With or Without Acute Coronary Syndrome: AIDA Trial Substudy

Author

Tijssen, Ruben, primary, Kerkmeijer, Laura, additional, Hofma, Sjoerd H., additional, van der Schaaf, Rene, additional, Weevers, Auke, additional, Kraak, Robin, additional, Piek, Jan, additional, Tijssen, Jan, additional, de Winter, Robert, additional, Henriques, Jose P.S., additional, and Wykrzykowska, Joanna, additional

Published
2019
Full Text
View/download PDF

32. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial

Author

Kerkmeijer, Laura S.M., primary, Tijssen, Ruben Yannick G., additional, Hofma, Sjoerd H., additional, van der Schaaf, Rene J., additional, Arkenbout, Karin E., additional, Kraak, Robin P., additional, Weevers, Auke, additional, Piek, Jan J., additional, de Winter, Robbert J., additional, Tijssen, Jan G.P., additional, Henriques, Jose P.S., additional, Wykrzykowska, Joanna J., additional, Ijsselmuiden, Alexander, additional, Kauer, Floris, additional, Beijk, Marcel A., additional, Vis, Marije, additional, and Koch, Karel, additional

Published
2019
Full Text
View/download PDF

34. Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study.

Author

Kerkmeijer, Laura S.M., Tijssen, Ruben Y.G., Hofma, Sjoerd H., van der Schaaf, Rene J., Arkenbout, E. Karin, Weevers, Auke P.J.D., Kraak, Robin P., Onuma, Yoshinobu, Serruys, Patrick W., Piek, Jan J., Tijssen, Jan G.P., Henriques, Jose P.S., de Winter, Robbert J., and Wykrzykowska, Joanna J.

Published
2021
Full Text
View/download PDF

40. Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy

Author

Tijssen, Ruben Y.G., primary, Schaaf, Rene J., additional, Kraak, Robin P., additional, Vink, Maarten A., additional, Hofma, Sjoerd H., additional, Arkenbout, E. Karin, additional, Weevers, Auke P.J.D., additional, Kerkmeijer, Laura S.M., additional, Onuma, Yoshinobu, additional, Serruys, Patrick W., additional, Beijk, Marcel A.M., additional, Koch, Karel T., additional, Baan, Jan, additional, Vis, M. Marije, additional, Piek, Jan J., additional, Tijssen, Jan G.P., additional, Henriques, Jose P.S., additional, Winter, Robbert J., additional, and Wykrzykowska, Joanna J., additional

Published
2019
Full Text
View/download PDF

41. CLINICAL OUTCOMES AT 2 YEARS OF THE ABSORB BIORESORBABLE VASCULAR SCAFFOLD VERSUS THE XIENCE DRUG-ELUTING METALLIC STENT IN PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME VERSUS STABLE CORONARY DISEASE: AIDA TRIAL SUB-STUDY

Author

Tijssen, Ruben, primary, van der Schaaf, Rene J., additional, Kraak, Robin, additional, Kerkmeijer, Laura S.M., additional, Hofma, Sjoerd H., additional, Arkenbout, Karin, additional, Weevers, Auke P.J.D., additional, Onuma, Yoshinobu, additional, Serruys, Patrick, additional, Beijk, Marcel, additional, Baan, Jan, additional, Vis, Maartje, additional, Koch, Karel T., additional, Piek, Jan, additional, Tijssen, Jan, additional, Henriques, José, additional, de Winter, Robbert, additional, and Wykrzykowska, Joanna, additional

Published
2019
Full Text
View/download PDF

42. 500.02 Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study.

Author

Tijssen, Ruben Y.G., primary, van der Schaaf, Rene J., additional, Kraak, Robin P., additional, Vink, Maarten A., additional, Hofma, Sjoerd H., additional, Arkenbout, Karin, additional, Weevers, Auke P.J.D., additional, Kerkmeijer, Laura S.M., additional, Serruys, Patrick W., additional, Onuma, Yoshinobu, additional, Beijk, Marcel A.M., additional, Koch, Karel T., additional, Baan, Jan, additional, Vis, M Marije, additional, Piek, Jan J., additional, Tijssen, Jan GP., additional, Henriques, Jose PS., additional, de Winter, Robbert J., additional, and Wykrzykowska, Joanna J., additional

Published
2019
Full Text
View/download PDF

43. Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)

Author

Katagiri, Yuki, primary, Onuma, Yoshinobu, additional, Asano, Taku, additional, Iñiguez, Andres, additional, Jensen, Lisette Okkels, additional, Cequier, Àngel, additional, Hofma, Sjoerd H., additional, Christiansen, Evald Høj, additional, Suttorp, Maarten, additional, Brugaletta, Salvatore, additional, Räber, Lorenz, additional, Sabaté, Manel, additional, Windecker, Stephan, additional, and Serruys, Patrick W., additional

Published
2018
Full Text
View/download PDF

44. Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy.

Author

Tijssen, Ruben Y.G., Schaaf, Rene J., Kraak, Robin P., Vink, Maarten A., Hofma, Sjoerd H., Arkenbout, E. Karin, Weevers, Auke P.J.D., Kerkmeijer, Laura S.M., Onuma, Yoshinobu, Serruys, Patrick W., Beijk, Marcel A.M., Koch, Karel T., Baan, Jan, Vis, M. Marije, Piek, Jan J., Tijssen, Jan G.P., Henriques, Jose P.S., Winter, Robbert J., and Wykrzykowska, Joanna J.

Published
2020
Full Text
View/download PDF

45. Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI

Author

Tijssen, Ruben Yannick G., primary, Kraak, Robin P., additional, Hofma, Sjoerd H., additional, van der Schaaf, Rene J., additional, Arkenbout, E. Karin, additional, Weevers, Auke, additional, Elias, Joelle, additional, van Dongen, Ivo M., additional, Koch, Karel T., additional, Baan, Jan, additional, Vis, Marije, additional, de Winter, Robbert J., additional, Piek, Jan J., additional, Tijssen, Jan G.P., additional, Henriques, Jose P.S., additional, and Wykrzykowska, Joanna J., additional

Published
2018
Full Text
View/download PDF

46. Bioresorbable Scaffolds versus Metallic Stents in Routine PCI

Author

Wykrzykowska, Joanna J., primary, Kraak, Robin P., additional, Hofma, Sjoerd H., additional, van der Schaaf, Rene J., additional, Arkenbout, E. Karin, additional, IJsselmuiden, Alexander J., additional, Elias, Joëlle, additional, van Dongen, Ivo M., additional, Tijssen, Ruben Y.G., additional, Koch, Karel T., additional, Baan, Jan, additional, Vis, M. Marije, additional, de Winter, Robbert J., additional, Piek, Jan J., additional, Tijssen, Jan G.P., additional, and Henriques, Jose P.S., additional

Published
2017
Full Text
View/download PDF

47. TCT-430 Baseline and procedural characteristics in the Amsterdam Investigator-initiateD randomized Absorb Trial

Author

Wykrzykowska, Joanna, primary, Kraak, Robin, additional, Elias, Joelle, additional, van Dongen, Ivo, additional, Hofma, Sjoerd H., additional, van der Schaaf, Rene, additional, Arkenbout, Karin, additional, Ijsselmuiden, Alexander, additional, Koch, Karel, additional, Baan, Jan, additional, Vis, Marije, additional, Tijssen, Jan, additional, Piek, Jan, additional, de Winter, Robert, additional, and Henriques, Jose PS., additional

Published
2016
Full Text
View/download PDF

48. TCT-161 5 years follow-up of biolimus eluting stents versus everolimus eluting in ST-segment elevation myocardial infarction presenting patients: Results from Compare II trial

Author

Vlachojannis, George, primary, Paradies, Valeria, additional, Hofma, Sjoerd H., additional, Togni, Mario, additional, Vazquez, Nicolas, additional, Valdes, Mariano, additional, Voudris, Vassilis, additional, slagboom, ton, additional, Goy, Jean-Jacques, additional, Vuilliomenet, Andre, additional, Serra, Antonio, additional, Trillo, Ramiro, additional, Den Heijer, Peter, additional, van der Ent, Martin, additional, and Smits, Pieter, additional

Published
2016
Full Text
View/download PDF

49. TCT-472 Comparison biolimus- and everolimus-eluting stents in patients with complex lesions. Five year follow-up from the COMPARE II trial

Author

Paradies, Valeria, primary, Vlachojannis, George, additional, Hofma, Sjoerd H., additional, Togni, Mario, additional, Vazquez, Nicolas, additional, Valdes, Mariano, additional, Voudris, Vassilis, additional, slagboom, ton, additional, Goy, Jean-Jacques, additional, Vuilliomenet, Andre, additional, Serra, Antonio, additional, Trillo, Ramiro, additional, Den Heijer, Peter, additional, van der Ent, Martin, additional, and Smits, Pieter, additional

Published
2016
Full Text
View/download PDF

50. TCT-264 Abluminal biodegradable polymer biolimus-eluting versus durable polymer everolimus-eluting stent in patients with diabetes. 5 years follow-up from the COMPARE II trial.

Author

Paradies, Valeria, primary, Vlachojannis, George, additional, Hofma, Sjoerd H., additional, Togni, Mario, additional, Vazquez, Nicolas, additional, Valdes, Mariano, additional, Voudris, Vassilis, additional, slagboom, ton, additional, Goy, Jean-Jacques, additional, Vuilliomenet, Andre, additional, Serra, Antonio, additional, Trillo, Ramiro, additional, Den Heijer, Peter, additional, van der Ent, Martin, additional, and Smits, Pieter, additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results